secwatch.observer — SEC 8-K summary
======================================

Issuer:     EBR Systems, Inc. (EBRCZ)
CIK:        0001347123
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0001214659-26-000377
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EBR Systems reports Q4 2025 preliminary rev ~$900K; WiSE implants double QoQ, clinical studies advance
--------------------------------------------------------------------------------

- Preliminary Q4 revenue $870K-$935K; FY2025 revenue $1,552K-$1,617K (unaudited, subject to audit adjustments).
- Commercial WiSE implants doubled QoQ to 18 in Q4, reaching 30 total for the year; 9 new purchase agreements signed.
- WiSE-UP post-approval study enrolled 4 patients; TLC-AU feasibility study enrolled first patient in Australia.
- 11 additional physicians trained in Q4, bringing total trained to 33 across 21 centers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347123/000121465926000377/0001214659-26-000377-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347123/000121465926000377/b1122638k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-26-000377

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer